Chemclin Diagnostics Co (SHSE:688468) Institutional Ownership: 1.59% (As of Sep. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688468 Chemclin Diagnostics Co Ltd SHSE:688468
76 GF Score
Price ¥6.35
GF Value ¥6.13
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Chemclin Diagnostics Co Institutional Ownership?

Chemclin Diagnostics Co SHSE:688468 +0.47% 76 Institutional Ownership is 1.59% as of Sep. 07, 2026. GuruFocus rates SHSE:688468 with a GF Score™ of 76/100 and a GF Value™ of ¥6.13 (Fairly Valued). The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Chemclin Diagnostics Co's institutional ownership is 1.59%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Chemclin Diagnostics Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Chemclin Diagnostics Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Chemclin Diagnostics Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Chemclin Diagnostics Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemclin Diagnostics Co Institutional Ownership Chart

Chemclin Diagnostics Co Historical Data

The historical data trend for Chemclin Diagnostics Co can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 1.12 1.75 1.75 1.75 1.75 1.75 1.75 1.75 1.75 1.59
SHSE:688468
76GF Score
Chemclin Diagnostics Co Ltd SHSE:688468
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemclin Diagnostics Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 1.59% mean?
Chemclin Diagnostics Co (SHSE:688468) has a Institutional Ownership of 1.59% as of Sep. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Chemclin Diagnostics Co and its competitors.
Is Chemclin Diagnostics Co's Institutional Ownership too high?
Chemclin Diagnostics Co's current Institutional Ownership is 1.59%. Overall, Chemclin Diagnostics Co has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chemclin Diagnostics Co's Institutional Ownership compare to TMO and DHR?
Chemclin Diagnostics Co's Institutional Ownership of 1.59% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Diagnostics & Research company?
A good Institutional Ownership depends on the Medical Diagnostics & Research industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Chemclin Diagnostics Co and its competitors. Chemclin Diagnostics Co's current Institutional Ownership is 1.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemclin Diagnostics Co stock overvalued right now?
Based on GuruFocus' analysis, Chemclin Diagnostics Co (SHSE:688468) is currently considered Fairly Valued. The stock's GF Value™ is ¥6.13, compared to a current price of ¥6.35 — trading 3.6% above its estimated fair value. The current Institutional Ownership is 1.59%. Chemclin Diagnostics Co's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Chemclin Diagnostics Co (SHSE:688468), the current Institutional Ownership is 1.59% as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemclin Diagnostics Co (SHSE:688468) Overvalued in 2026?

Based on GuruFocus' analysis, Chemclin Diagnostics Co stock appears to be overvalued. The current stock price of ¥6.35 is trading 3.6% above its estimated GF Value™ of ¥6.13. GuruFocus considers Chemclin Diagnostics Co to be Fairly Valued.

Key valuation signals for SHSE:688468:

  • Institutional Ownership: 1.59%
  • GF Value™: ¥6.13 vs. price of ¥6.35 (3.6% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chemclin Diagnostics Co Business Description

Address No. 7 Fengxian Middle Road, 6th & 7th Floor Incubator Building, Beike Modern Manufacturing Park, Yongfeng Base, Haidian District, Beijing, CHN, 100094
Chemclin Diagnostics Co Ltd is engaged in the development, production and sales of clinical immunochemiluminescence diagnostic testing reagents and instruments.
76GF Score

Get the complete analysis for SHSE:688468

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.35
Price
¥6.13
GF Value